A new study, described as the largest on human ivermectin and cancer, reportedly found that nearly half of cancers in patients saw disappearance or massive regression after six months of treatment. Nicholas Holsinger of the McCullough Foundation shared the findings, which involved patients with even late-stage cancers. The discussion includes a significant claim that the CIA knew 50 years ago that anti-parasitics could reduce tumors but classified the information. It’s alleged this was to protect a "chemo cartel," as ivermectin, often paired with mebendazole, poses a low-profit alternative.